Sensus Healthcare, Inc.

    Jurisdiction
    United States
    LEI
    549300F3JF8NCDJJZW04
    ISIN
    US81728J1097 (SRTS)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    €11.42 293.7% undervalued
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. Read full profile

    Fundamentals

    Net revenue
    €33.68M
    Gross margin
    56.0%
    EBIT
    €2.18M
    EBIT margin
    6.5%
    Net income
    €1.54M
    Net margin
    4.6%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €38.72M +14.9% €2.99M +94.9%
    €51.26M +32.4% €8.87M +196.3%
    N/A N/A

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Sardano Michael PRESIDENT AND GENERAL COUNSEL +1K $3.37 +$3.37K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 260K $1.23M -171K Sell

    Earnings Calls

    Latest earnings call: August 8, 2025 (Q2 2025)

    Add to watchlist

    Notifications